
For High Net Worth & Sophisticated Investors
Targeting >50% IRR via primary or secondary exits, within 2-3 years
This is your chance to not only secure those tax benefits, but also invest in an explosive mental health tech brand with positive social impact at its core.

For High Net Worth & Sophisticated Investors
Targeting >50% IRR via primary or secondary exits, within 2-3 years

For experienced investors who value integrity and intelligence, to achieve exceptional financial outcomes and positive impact.
Bolt Angels is a founder-led investment firm built on 30+ years of experience, direct alignment, and full transparency.

Diversified exposure: one investment - two fast-scaling venture companies (JAAQ + CUDO)
Board-level governance: we hold active board seats in both companies
Real traction: Both companies with strong balance sheets and significant revenues
No management or performance fees on Bolt Angels share purchases
Additional opportunities for passive income-bearing investments
Invest alongside 70+ Capital Partners and the General Partners.
Venture Stage. Values-driven. Aligned outcomes.
Operating at the leading edge of AI and sharing best practice with Partners
Diversified exposure: one investment - two fast-scaling venture companies (JAAQ + CUDO)
Board-level governance: we hold active board seats in both companies
Real traction: Both companies with strong balance sheets and significant revenues
No management or performance fees on Bolt Angels share purchases
Additional opportunities for passive income-bearing investments
Invest alongside 70+ Capital Partners and the General Partners
Venture Stage. Values-driven. Aligned outcomes
Operating at the leading edge of AI and sharing best practice with Partners



Conversations with world-leading clinicians, influencers, and global brands
Strategic partnerships with Bupa, corporates, and content providers
Targeting >8x growth in enterprise value between 2025 - 2027

High-performance GPU compute marketplace for AI, machine learning, etc
Over $83M in revenue booked to date
Strategic alignment with NVIDIA and the Artificial Super Intelligence Alliance
Targeting >4x growth in enterprise value between 2025 - 2027

Bolt Angels only backs high-integrity, high-potential scale ups (max. one per annum)
Capital deployed through a single investment entity - Bolt Angels
Governance-first. Outcome-focused. No hype.
High-calibre network of 70+ Partners and hundreds of Limited Partners

ACTIVE INVESTORS IN WORLD CLASS OPPORTUNITIES

Bolt Angels only backs high-integrity, high-potential scale ups (max. one per annum)
Capital deployed through a single investment entity - Bolt Angels
Governance-first. Outcome-focused. No hype.
High-calibre network of 70+ Partners and hundreds of Limited Partners


Exciting point 1
Exciting point 2
Exciting point 3


Exciting point 1
Exciting point 2
Exciting point 3
High Net Worth or Sophisticated Investors
With £50k+ available capital
Long-term value creation mindset
Alignment with exponential AI and positive impact
High Net Worth or Sophisticated Investors
With £50k+ available capital
Long-term value creation mindset
Alignment with exponential AI and positive impact
Disclaimer
This site is exempt from the general restriction in section 21 of the Financial Services and Markets Act 2000 on the communication of invitations or inducements to engage in investment activity on the grounds it is made exclusively to persons believed on reasonable grounds to be either:
(i) ‘high net worth individuals’ within the meaning of Article 48 of the Financial Services and Markets Act (Financial Promotion) Order 2005 (‘FinProm’), or
(ii) ‘self-certified sophisticated investors’ within the meaning of Article 50A FinProm.
This opportunity is directed only to individuals who qualify as high-net-worth individuals or sophisticated investors under the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005. Past performance is not a guarantee of future results, and investments are subject to risk. Please consult with your financial advisor before making any investment decisions.

Company No: 12864863
Monomark House, 27 Old Gloucester Street, London WC1N 3AX
[email protected]

Company No: 12864863
Monomark House, 27 Old Gloucester Street,
London WC1N 3AX
[email protected]